Education
About Us
Working with TipRanks
Follow Us
Q32 Bio (QTTB)
NASDAQ:QTTB
Total Valuation
Q32 Bio has a market cap or net worth of $19.52M. The enterprise value is -$17.16M.
Market Cap$19.52M
Enterprise Value-$17.16M
Share Statistics
Q32 Bio has 12,197,615 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,197,615
Owned by Insiders2.72%
Owned by Institutions<0.01%
Financial Efficiency
Q32 Bio’s return on equity (ROE) is -1.55 and return on invested capital (ROIC) is -31.24%.
Return on Equity (ROE)-1.55
Return on Assets (ROA)-0.37
Return on Invested Capital (ROIC)-31.24%
Return on Capital Employed (ROCE)-0.31
Revenue Per Employee27.52K
Profits Per Employee-2.69M
Employee Count42
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Q32 Bio is -1.16. Q32 Bio’s PEG ratio is 0.02.
PE Ratio-1.16
PS Ratio0.00
PB Ratio1.79
Price to Fair Value1.79
Price to FCF-1.35
Price to Operating Cash Flow-1.36
PEG Ratio0.02
Income Statement
In the last 12 months, Q32 Bio had revenue of 1.16M and earned -112.96M in profits. Earnings per share was -4.51.
Revenue1.16M
Gross Profit578.00K
Operating Income-92.10M
Pretax Income-87.08M
Net Income-112.96M
EBITDA-86.50M
Earnings Per Share (EPS)-4.51
Cash Flow
In the last 12 months, operating cash flow was -67.72M and capital expenditures -75.00K, giving a free cash flow of -67.79M billion.
Operating Cash Flow-67.72M
Free Cash Flow-67.79M
Free Cash Flow per Share-5.56
Dividends & Yields
Q32 Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.05
52-Week Price Change-93.79%
50-Day Moving Average1.98
200-Day Moving Average21.94
Relative Strength Index (RSI)40.20
Average Volume (3m)171.82K
Important Dates
Q32 Bio upcoming earnings date is May 8, 2025, TBA Not Confirmed.
Last Earnings DateMar 11, 2025
Next Earnings DateMay 8, 2025
Ex-Dividend Date―
Financial Position
Q32 Bio as a current ratio of 7.25, with Debt / Equity ratio of 333.06%
Current Ratio7.25
Quick Ratio7.25
Debt to Market Cap0.01
Net Debt to EBITDA-0.13
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Q32 Bio has paid 318.00K in taxes.
Income Tax318.00K
Effective Tax Rate>-0.01
Enterprise Valuation
Q32 Bio EV to EBITDA ratio is -1.64, with an EV/FCF ratio of -1.47.
EV to Sales122.91
EV to EBITDA-1.64
EV to Free Cash Flow-1.47
EV to Operating Cash Flow-1.48
Balance Sheet
Q32 Bio has $77.97M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$59.06M billion.
Cash & Marketable Securities$77.97M
Total Debt$0.00
Net Cash-$59.06M
Net Cash Per Share-$4.84
Tangible Book Value Per Share$6.12
Margins
Gross margin is 0.00%, with operating margin of -7967.30%, and net profit margin of -9771.71%.
Gross Margin0.00%
Operating Margin-7967.30%
Pretax Margin-7532.87%
Net Profit Margin-9771.71%
EBITDA Margin-7482.87%
EBIT Margin-7532.87%
Analyst Forecast
The average price target for Q32 Bio is $13.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$13.00
Price Target Upside733.33% Upside
Analyst ConsensusHold
Analyst Count4
Revenue Growth Forecast-100.00%
EPS Growth Forecast91.45%